Earnings summaries and quarterly performance for Westlake Chemical Partners.
Research analysts who have asked questions during Westlake Chemical Partners earnings calls.
Recent press releases and 8-K filings for WLKP.
Westlake Chemical Partners Reports Q3 2025 Results and Renews Ethylene Sales Agreement
WLKP
Earnings
Dividends
Guidance Update
- Westlake Chemical Partners reported Third Quarter 2025 net income of $15 million, or $0.42 per unit, with consolidated net income of $86 million on consolidated net sales of $309 million.
- The Partnership's distributable cash flow for Q3 2025 was $15 million, or $0.42 per unit, representing a $3 million decrease compared to Q3 2024, primarily due to higher maintenance capital expenditures and lower margins on third-party ethylene sales. The planned turnaround in Q2 2025 also impacted cash flows, but the company expects full coverage from its operating surplus now that the turnaround is complete.
- A quarterly distribution of $0.4714 per unit for Q3 2025 was announced, payable on November 26, 2025. The ethylene sales agreement was renewed through the end of 2027 with Westlake Corporation, maintaining stable pricing and sales volume protections.
- The company ended Q3 2025 with $51 million in consolidated cash and $400 million in long-term debt, maintaining a consolidated leverage ratio of approximately one time. No planned turnarounds are scheduled for the remainder of 2025 or in 2026.
Oct 30, 2025, 5:00 PM
Westlake Reports Q3 2025 Financial Results with Significant Goodwill Impairment
WLKP
Earnings
Guidance Update
Demand Weakening
- Westlake reported net sales of $2.8 billion and EBITDA of $313 million for Q3 2025.
- The company incurred a net loss attributable to Westlake Corporation of $(782) million, or $(6.06) diluted earnings per share, primarily due to a $727 million non-cash goodwill impairment charge in North America Chlorovinyls.
- Westlake achieved ~$115 million in company-wide cost savings year-to-date, including $40 million in Q3 2025, and is progressing towards $200 million in identified cost savings for 2026.
- The Housing and Infrastructure Products (HIP) segment demonstrated solid sales and EBITDA, with sales growth outpacing the market, while the Performance and Essential Materials (PEM) segment's operating rate and sales volume improved as Q3 2025 progressed.
Oct 30, 2025, 5:00 PM
Westlake Chemical Partners Renews Ethylene Sales Agreement Through 2027
WLKP
Dividends
New Projects/Investments
- Westlake Chemical Partners LP has renewed its Ethylene Sales Agreement with Westlake Corporation through December 31, 2027, maintaining the pricing formula and sales volume protections for 95% of ethylene production. This renewal is crucial for ensuring stable and predictable cash flows, enabling the Partnership to sustain its record of 45 consecutive quarterly distributions.
- Despite a decline in third quarter 2025 net income and distributable cash flow due to higher maintenance capital expenditures, the Partnership's cash flow remained stable because of the fee-based structure with take-or-pay protections in the agreement.
- The renewal also includes amendments to the Services and Secondment Agreement and Omnibus Agreement to align terms and clarify indemnification obligations, and Westlake Chemical Partners owns a 22.8% interest in Westlake Chemical OpCo LP, which operates three ethylene production facilities and an ethylene pipeline.
Oct 30, 2025, 4:13 PM
Westlake Chemical Partners LP Renews Key Sales Agreement and Reports Q3 2025 Results
WLKP
Earnings
Dividends
- Westlake Chemical Partners LP (WLKP) announced the renewal of its Ethylene Sales Agreement with Westlake Chemical OpCo LP and Westlake Corporation through December 31, 2027. This renewal maintains the same pricing formula and sales volume protections, ensuring the continued offtake of 95% of OpCo's ethylene production.
- For the third quarter of 2025, net income attributable to the Partnership was $14.7 million, and MLP distributable cash flow was $14.9 million. These figures represent a decrease from Q3 2024, which saw net income of $18.1 million and MLP distributable cash flow of $17.9 million. Cash flows from operating activities for Q3 2025 were $105.2 million, a decrease from $126.1 million in Q3 2024, but a significant increase from $9.1 million in Q2 2025 due to a decline in cash payments related to a turnaround.
- The Partnership declared its 45th consecutive quarterly distribution of $0.4714 per unit for Q3 2025. The trailing twelve-month coverage ratio for Q3 2025 was 0.75x, down from 0.79x at the end of Q2 2025, primarily due to higher maintenance capital expenditures.
Oct 30, 2025, 11:33 AM
Quarterly earnings call transcripts for Westlake Chemical Partners.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more